Eur Respir J 2008, doi:10.1183/09031936.00137107
Leukotriene B4: early mediator of atherosclerosis in obstructive sleep apnoea?
1 INSERM, ERI17, Grenoble, F-38042 France; Université Grenoble 1, Faculté de Médecine, IFR1, Grenoble, F-38042 France; and CHU, Hôpital A. Michallon, Laboratoire de pharmacologie, BP217, Grenoble, F-38043 France
* To whom correspondence should be addressed. E-mail: FStanke{at}chu-grenoble.fr.
Severity of oxygen desaturation is predictive of early atherosclerosis in obstructive sleep apnoea (OSA). Leukotrienes B4 (LTB4) are lipid mediators involved in atherogenesis. In 40 non obese OSA patients free of cardiovascular history and in 20 healthy volunteers, we evaluated 1/ the LTB4 production by polymorphonuclear leukocytes (PMNs) stimulated by A23187, 2/ the relationships between LTB4 production and both OSA severity and infra-clinical atherosclerosis markers. Continuous positive airway pressure (CPAP) effect on LTB4 production was also studied. Overnight sleep study was followed by a first-morning blood sample. Isolated PMNs were stimulated by A23187 in order to induce LTB4 production that was measured by liquid chromatography-tandem mass spectrometry. Carotid intima-media thickness (IMT) and luminal diameter (LD) were measured in subset groups of 28 OSA and 11 controls. LTB4 production was increased (p<0.05) in OSA compared to controls. LTB4 values were correlated with the mean SaO2 (r=-0.53, p<0.001) and minimal SaO2 (r=-0.51, p<0.001). LTB4 production was correlated to LD data in patients with mean SaO2 LTB4 production is increased in OSA in relation to oxygen desaturation. LTB4 could promote early vascular remodelling in moderate to severe hypoxic OSA patients. Keywords: Atherosclerosis; leukotriene B4; polymorphonuclear cells; sleep apnoea
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||